2,5-Dimethoxy-4-propylamphetamine: Difference between revisions
Appearance
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report [[Wikipedia talk:WikiProject_Pharmacology|errors |
No edit summary |
||
(37 intermediate revisions by 26 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Psychedelic drug}} |
|||
{{one source|date=April 2015}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| width = 230px |
|||
⚫ | |||
⚫ | |||
| width = 200px |
|||
⚫ | |||
| InChIKey = UEEAUFJYLUJWQJ-UHFFFAOYAM |
|||
<!--Clinical data--> |
|||
| tradename = |
|||
⚫ | |||
| legal_CA = Schedule I |
|||
| legal_DE = NpSG |
|||
| legal_UK = Class A |
|||
⚫ | |||
⚫ | |||
<!--Pharmacokinetic data--> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Identifiers--> |
|||
| CAS_number_Ref = {{cascite|changed|??}} |
|||
⚫ | |||
| CAS_supplemental = <BR> 53581-55-8 (hydrochloride) |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = L3P287BI9W |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
||
| ChEMBL = 8569 |
| ChEMBL = 8569 |
||
⚫ | |||
<!--Chemical data--> |
|||
| StdInChI = 1S/C14H23NO2/c1-5-6-11-8-14(17-4)12(7-10(2)15)9-13(11)16-3/h8-10H,5-7,15H2,1-4H3 |
|||
| C=14 | H=23 | N=1 | O=2 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = UEEAUFJYLUJWQJ-UHFFFAOYSA-N |
| StdInChIKey = UEEAUFJYLUJWQJ-UHFFFAOYSA-N |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| chemical_formula = C<sub>14</sub>H<sub>23</sub>NO<sub>2</sub> |
|||
| molecular_weight = 237.34 g/mol |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
}} |
}} |
||
'''2,5-Dimethoxy-4-propylamphetamine''' ('''DOPR''') is a [[ |
'''2,5-Dimethoxy-4-propylamphetamine''' ('''DOPR''') is a [[psychedelic drug|psychedelic]] [[drug]] of the [[substituted phenethylamine|phenethylamine]] and [[substituted amphetamine|amphetamine]] [[chemical class]]es. It was first [[Organic synthesis|synthesized]] by [[Alexander Shulgin]], and was described in his book ''[[PiHKAL]]'' (''Phenethylamines i Have Known And Loved''). Shulgin described DOPR as a "heavy duty psychedelic", complete with alterations of the thought process and visual distortion.<ref name="PiHKAL">{{cite book | title = PiHKAL: A Chemical Love Story | vauthors = Shulgin A, Shulgin A | publisher = Transform Press | location = United States | isbn = 0-9630096-0-5 | pages = 978 | url = http://www.erowid.org/library/books_online/pihkal/pihkal.shtml |date= September 1991}}</ref> Very little data exists about the pharmacological properties, metabolism, and toxicity of DOPR. |
||
The alternative structural isomer DOIP, with a 4-isopropyl substitution, is also known but is around ten times weaker than DOPR, with an active dose of some |
The alternative structural isomer [[2,5-Dimethoxy-4-isopropylamphetamine|DOIP]], with a 4-isopropyl substitution, is also known but is around ten times weaker than DOPR, with an active dose of some 20–30 mg (as compared to 2–5 mg for DOPR).<ref name="PiHKAL"/> |
||
[[Image:DOIP_structure.png|180px|thumb|left|Structure of DOIP]]{{clear-left}} |
[[Image:DOIP_structure.png|180px|thumb|left|Structure of DOIP]]{{clear-left}} |
||
== See also == |
== See also == |
||
* [[DOPF]] |
|||
* [[2,5-Dimethoxy-4-Substituted Amphetamine]]s |
|||
* [[DOx]] |
|||
== References == |
== References == |
||
{{Reflist |
{{Reflist}} |
||
== External links == |
|||
* [http://www.erowid.org/library/books_online/pihkal/pihkal071.shtml DOPR Entry in ''PiHKAL''] |
|||
* [http://pihkal.info/read.php?domain=pk&id=71 DOPR Entry in PiHKAL • info] |
|||
{{Hallucinogens}} |
{{Hallucinogens}} |
||
{{Serotonergics}} |
{{Serotonergics}} |
||
{{Phenethylamines}} |
{{Phenethylamines}} |
||
⚫ | |||
[[Category:2C (psychedelics)]] |
|||
{{DEFAULTSORT:Dimethoxy-4-propylamphetamine, 2,5-}} |
{{DEFAULTSORT:Dimethoxy-4-propylamphetamine, 2,5-}} |
||
[[Category:Substituted amphetamines]] |
|||
⚫ | |||
{{ |
{{hallucinogen-stub}} |
Latest revision as of 15:42, 5 October 2024
This article relies largely or entirely on a single source. (April 2015) |
Clinical data | |
---|---|
Other names | 2,5-Dimethoxy-4-propylamphetamine |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H23NO2 |
Molar mass | 237.343 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
2,5-Dimethoxy-4-propylamphetamine (DOPR) is a psychedelic drug of the phenethylamine and amphetamine chemical classes. It was first synthesized by Alexander Shulgin, and was described in his book PiHKAL (Phenethylamines i Have Known And Loved). Shulgin described DOPR as a "heavy duty psychedelic", complete with alterations of the thought process and visual distortion.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of DOPR.
The alternative structural isomer DOIP, with a 4-isopropyl substitution, is also known but is around ten times weaker than DOPR, with an active dose of some 20–30 mg (as compared to 2–5 mg for DOPR).[1]
See also
[edit]References
[edit]- ^ a b Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. United States: Transform Press. p. 978. ISBN 0-9630096-0-5.